Contact Us
Drug Search Results
More Filters [+]

Acitretin

Alternative Names: acitretin, neotigason, u0279, soriatane
Latest Update: 2024-12-18
Latest Update Note: Clinical Trial Update

Product Description

Acitretin is an oral retinoid (vitamin-A derivative) used to treat severe psoriasis, usually at a dose of 0.251 mg per kg body weight per day. It is best taken after a meal because it needs fat to be absorbed through the gut wall. Acitretin is available as 10 mg and 25 mg capsules.

Mechanisms of Action: RAR Agonist,ADAM Activator

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Austria | Bangladesh | Belgium | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Czech | Denmark | Dominican Republic | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lithuania | Luxembourg | Malaysia | Malta | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Poland | Portugal | Russia | Saudi Arabia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Acitretin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

03/14/2024

News Article

 Psoriasis in America - Insights into Psoriasis Patient Demographics, Quality of Life, Information-seeking Behaviors, HCP Engagement and Treatment Experiences

09/10/2023

News Article

 Acitretin market report gives users access to a comprehensive view and a company market share analysis of major industry competitors & projected a CAGR of 6.3% from 2023-2030

09/10/2023

News Article

 The latest trend analysis by ReportPrime suggests that the Acitretin Capsules market will witness robust competition tracking and significant growth, with a projected CAGR of 11% from 2023 to 2030

06/29/2023

News Article

 Can-Fite Receives U.S. FDA's Go Ahead for Piclidenoson Psoriasis Registration Plan

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions